Medical Care
Global Nuclear Medicine Market Research Report 2025
- May 12, 25
- ID: 56875
- Pages: 82
- Figures: 84
- Views: 10
The global market for Nuclear Medicine was valued at US$ 7131 million in the year 2024 and is projected to reach a revised size of US$ 11670 million by 2031, growing at a CAGR of 7.4% during the forecast period.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Nuclear Medicine，or Radiopharmaceuticals， are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
North America is the largest consumption area, with a consumption market share nearly 50%. Following North America, Europe is the second place consumption region with the consumption market share of about 25%.
Global Nuclear Medicine key manufacturers include GE Healthcare, Bracco Imaging, etc. The global top 2 manufacturers account for over 30 percent of total share.
The classification of Nuclear Medicine includes Tc-99, I-123/131, In-111, Xe-133, Th-201 and Ga-67, and the proportion of Tc-99 is about 50%.
Nuclear Medicine is widely used in Diagnostic, Therapeutic. The most proportion of Nuclear Medicine is Diagnostic, and the market share is over 60%.
This report aims to provide a comprehensive presentation of the global market for Nuclear Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nuclear Medicine.
The Nuclear Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nuclear Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nuclear Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bracco Imaging
Mallinckrodt
Lantheus Medical Imaging
Bayer
Triad Isotopes
Nordion
Jubilant Pharma
Eli Lilly
SIEMENS
China Isotope & Radiation
Dongcheng
Segment by Type
Tc-99
I-123/131
In-111
Xe-133
Th-201
Ga-67
Others
Segment by Application
Diagnostic
Therapeutic
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nuclear Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Medicine Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
3.5 Global Key Players of Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Nuclear Medicine, Product and Application
3.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Medicine Market Size (2020-2031)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Medicine Market Size by Country (2020-2025)
6.4 North America Nuclear Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2020-2031)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.4 Europe Nuclear Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2020-2031)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Medicine Market Size by Country (2020-2025)
9.4 Latin America Nuclear Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Details
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2020-2025)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Details
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2020-2025)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Details
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Details
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Details
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nuclear Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tc-99
1.2.3 I-123/131
1.2.4 In-111
1.2.5 Xe-133
1.2.6 Th-201
1.2.7 Ga-67
1.2.8 Others
1.3 Market by Application
1.3.1 Global Nuclear Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Diagnostic
1.3.3 Therapeutic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Nuclear Medicine Market Perspective (2020-2031)
2.2 Global Nuclear Medicine Growth Trends by Region
2.2.1 Global Nuclear Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Nuclear Medicine Historic Market Size by Region (2020-2025)
2.2.3 Nuclear Medicine Forecasted Market Size by Region (2026-2031)
2.3 Nuclear Medicine Market Dynamics
2.3.1 Nuclear Medicine Industry Trends
2.3.2 Nuclear Medicine Market Drivers
2.3.3 Nuclear Medicine Market Challenges
2.3.4 Nuclear Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nuclear Medicine Players by Revenue
3.1.1 Global Top Nuclear Medicine Players by Revenue (2020-2025)
3.1.2 Global Nuclear Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Nuclear Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Nuclear Medicine Revenue
3.4 Global Nuclear Medicine Market Concentration Ratio
3.4.1 Global Nuclear Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nuclear Medicine Revenue in 2024
3.5 Global Key Players of Nuclear Medicine Head office and Area Served
3.6 Global Key Players of Nuclear Medicine, Product and Application
3.7 Global Key Players of Nuclear Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Nuclear Medicine Breakdown Data by Type
4.1 Global Nuclear Medicine Historic Market Size by Type (2020-2025)
4.2 Global Nuclear Medicine Forecasted Market Size by Type (2026-2031)
5 Nuclear Medicine Breakdown Data by Application
5.1 Global Nuclear Medicine Historic Market Size by Application (2020-2025)
5.2 Global Nuclear Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Nuclear Medicine Market Size (2020-2031)
6.2 North America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Nuclear Medicine Market Size by Country (2020-2025)
6.4 North America Nuclear Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Nuclear Medicine Market Size (2020-2031)
7.2 Europe Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Nuclear Medicine Market Size by Country (2020-2025)
7.4 Europe Nuclear Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nuclear Medicine Market Size (2020-2031)
8.2 Asia-Pacific Nuclear Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Nuclear Medicine Market Size (2020-2031)
9.2 Latin America Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Nuclear Medicine Market Size by Country (2020-2025)
9.4 Latin America Nuclear Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nuclear Medicine Market Size (2020-2031)
10.2 Middle East & Africa Nuclear Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare Nuclear Medicine Introduction
11.1.4 GE Healthcare Revenue in Nuclear Medicine Business (2020-2025)
11.1.5 GE Healthcare Recent Development
11.2 Bracco Imaging
11.2.1 Bracco Imaging Company Details
11.2.2 Bracco Imaging Business Overview
11.2.3 Bracco Imaging Nuclear Medicine Introduction
11.2.4 Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.2.5 Bracco Imaging Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Details
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Nuclear Medicine Introduction
11.3.4 Mallinckrodt Revenue in Nuclear Medicine Business (2020-2025)
11.3.5 Mallinckrodt Recent Development
11.4 Lantheus Medical Imaging
11.4.1 Lantheus Medical Imaging Company Details
11.4.2 Lantheus Medical Imaging Business Overview
11.4.3 Lantheus Medical Imaging Nuclear Medicine Introduction
11.4.4 Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2020-2025)
11.4.5 Lantheus Medical Imaging Recent Development
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Nuclear Medicine Introduction
11.5.4 Bayer Revenue in Nuclear Medicine Business (2020-2025)
11.5.5 Bayer Recent Development
11.6 Triad Isotopes
11.6.1 Triad Isotopes Company Details
11.6.2 Triad Isotopes Business Overview
11.6.3 Triad Isotopes Nuclear Medicine Introduction
11.6.4 Triad Isotopes Revenue in Nuclear Medicine Business (2020-2025)
11.6.5 Triad Isotopes Recent Development
11.7 Nordion
11.7.1 Nordion Company Details
11.7.2 Nordion Business Overview
11.7.3 Nordion Nuclear Medicine Introduction
11.7.4 Nordion Revenue in Nuclear Medicine Business (2020-2025)
11.7.5 Nordion Recent Development
11.8 Jubilant Pharma
11.8.1 Jubilant Pharma Company Details
11.8.2 Jubilant Pharma Business Overview
11.8.3 Jubilant Pharma Nuclear Medicine Introduction
11.8.4 Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025)
11.8.5 Jubilant Pharma Recent Development
11.9 Eli Lilly
11.9.1 Eli Lilly Company Details
11.9.2 Eli Lilly Business Overview
11.9.3 Eli Lilly Nuclear Medicine Introduction
11.9.4 Eli Lilly Revenue in Nuclear Medicine Business (2020-2025)
11.9.5 Eli Lilly Recent Development
11.10 SIEMENS
11.10.1 SIEMENS Company Details
11.10.2 SIEMENS Business Overview
11.10.3 SIEMENS Nuclear Medicine Introduction
11.10.4 SIEMENS Revenue in Nuclear Medicine Business (2020-2025)
11.10.5 SIEMENS Recent Development
11.11 China Isotope & Radiation
11.11.1 China Isotope & Radiation Company Details
11.11.2 China Isotope & Radiation Business Overview
11.11.3 China Isotope & Radiation Nuclear Medicine Introduction
11.11.4 China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025)
11.11.5 China Isotope & Radiation Recent Development
11.12 Dongcheng
11.12.1 Dongcheng Company Details
11.12.2 Dongcheng Business Overview
11.12.3 Dongcheng Nuclear Medicine Introduction
11.12.4 Dongcheng Revenue in Nuclear Medicine Business (2020-2025)
11.12.5 Dongcheng Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tc-99
Table 3. Key Players of I-123/131
Table 4. Key Players of In-111
Table 5. Key Players of Xe-133
Table 6. Key Players of Th-201
Table 7. Key Players of Ga-67
Table 8. Key Players of Others
Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Nuclear Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Nuclear Medicine Market Share by Region (2020-2025)
Table 13. Global Nuclear Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Nuclear Medicine Market Share by Region (2026-2031)
Table 15. Nuclear Medicine Market Trends
Table 16. Nuclear Medicine Market Drivers
Table 17. Nuclear Medicine Market Challenges
Table 18. Nuclear Medicine Market Restraints
Table 19. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 25. Global Key Players of Nuclear Medicine, Product and Application
Table 26. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 32. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 36. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 51. GE Healthcare Company Details
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Bracco Imaging Company Details
Table 57. Bracco Imaging Business Overview
Table 58. Bracco Imaging Nuclear Medicine Product
Table 59. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 60. Bracco Imaging Recent Development
Table 61. Mallinckrodt Company Details
Table 62. Mallinckrodt Business Overview
Table 63. Mallinckrodt Nuclear Medicine Product
Table 64. Mallinckrodt Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 65. Mallinckrodt Recent Development
Table 66. Lantheus Medical Imaging Company Details
Table 67. Lantheus Medical Imaging Business Overview
Table 68. Lantheus Medical Imaging Nuclear Medicine Product
Table 69. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 70. Lantheus Medical Imaging Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Nuclear Medicine Product
Table 74. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Triad Isotopes Company Details
Table 77. Triad Isotopes Business Overview
Table 78. Triad Isotopes Nuclear Medicine Product
Table 79. Triad Isotopes Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 80. Triad Isotopes Recent Development
Table 81. Nordion Company Details
Table 82. Nordion Business Overview
Table 83. Nordion Nuclear Medicine Product
Table 84. Nordion Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 85. Nordion Recent Development
Table 86. Jubilant Pharma Company Details
Table 87. Jubilant Pharma Business Overview
Table 88. Jubilant Pharma Nuclear Medicine Product
Table 89. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 90. Jubilant Pharma Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. SIEMENS Company Details
Table 97. SIEMENS Business Overview
Table 98. SIEMENS Nuclear Medicine Product
Table 99. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 100. SIEMENS Recent Development
Table 101. China Isotope & Radiation Company Details
Table 102. China Isotope & Radiation Business Overview
Table 103. China Isotope & Radiation Nuclear Medicine Product
Table 104. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 105. China Isotope & Radiation Recent Development
Table 106. Dongcheng Company Details
Table 107. Dongcheng Business Overview
Table 108. Dongcheng Nuclear Medicine Product
Table 109. Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 110. Dongcheng Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 4. Tc-99 Features
Figure 5. I-123/131 Features
Figure 6. In-111 Features
Figure 7. Xe-133 Features
Figure 8. Th-201 Features
Figure 9. Ga-67 Features
Figure 10. Others Features
Figure 11. Global Nuclear Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 13. Diagnostic Case Studies
Figure 14. Therapeutic Case Studies
Figure 15. Nuclear Medicine Report Years Considered
Figure 16. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Nuclear Medicine Market Share by Region: 2024 VS 2031
Figure 19. Global Nuclear Medicine Market Share by Players in 2024
Figure 20. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 22. North America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Nuclear Medicine Market Share by Country (2020-2031)
Figure 24. United States Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Nuclear Medicine Market Share by Country (2020-2031)
Figure 28. Germany Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Nuclear Medicine Market Share by Region (2020-2031)
Figure 36. China Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Nuclear Medicine Market Share by Country (2020-2031)
Figure 44. Mexico Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Nuclear Medicine Market Share by Country (2020-2031)
Figure 48. Turkey Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 52. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 53. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 54. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 56. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 57. Nordion Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 58. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 59. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 60. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 61. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 62. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Nuclear Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tc-99
Table 3. Key Players of I-123/131
Table 4. Key Players of In-111
Table 5. Key Players of Xe-133
Table 6. Key Players of Th-201
Table 7. Key Players of Ga-67
Table 8. Key Players of Others
Table 9. Global Nuclear Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Nuclear Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Nuclear Medicine Market Share by Region (2020-2025)
Table 13. Global Nuclear Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Nuclear Medicine Market Share by Region (2026-2031)
Table 15. Nuclear Medicine Market Trends
Table 16. Nuclear Medicine Market Drivers
Table 17. Nuclear Medicine Market Challenges
Table 18. Nuclear Medicine Market Restraints
Table 19. Global Nuclear Medicine Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Nuclear Medicine Market Share by Players (2020-2025)
Table 21. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Table 22. Ranking of Global Top Nuclear Medicine Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Nuclear Medicine Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Nuclear Medicine, Headquarters and Area Served
Table 25. Global Key Players of Nuclear Medicine, Product and Application
Table 26. Global Key Players of Nuclear Medicine, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Nuclear Medicine Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Nuclear Medicine Revenue Market Share by Type (2020-2025)
Table 30. Global Nuclear Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Nuclear Medicine Revenue Market Share by Type (2026-2031)
Table 32. Global Nuclear Medicine Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Nuclear Medicine Revenue Market Share by Application (2020-2025)
Table 34. Global Nuclear Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Nuclear Medicine Revenue Market Share by Application (2026-2031)
Table 36. North America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Nuclear Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Nuclear Medicine Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Nuclear Medicine Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Nuclear Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Nuclear Medicine Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Nuclear Medicine Market Size by Country (2026-2031) & (US$ Million)
Table 51. GE Healthcare Company Details
Table 52. GE Healthcare Business Overview
Table 53. GE Healthcare Nuclear Medicine Product
Table 54. GE Healthcare Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 55. GE Healthcare Recent Development
Table 56. Bracco Imaging Company Details
Table 57. Bracco Imaging Business Overview
Table 58. Bracco Imaging Nuclear Medicine Product
Table 59. Bracco Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 60. Bracco Imaging Recent Development
Table 61. Mallinckrodt Company Details
Table 62. Mallinckrodt Business Overview
Table 63. Mallinckrodt Nuclear Medicine Product
Table 64. Mallinckrodt Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 65. Mallinckrodt Recent Development
Table 66. Lantheus Medical Imaging Company Details
Table 67. Lantheus Medical Imaging Business Overview
Table 68. Lantheus Medical Imaging Nuclear Medicine Product
Table 69. Lantheus Medical Imaging Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 70. Lantheus Medical Imaging Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Nuclear Medicine Product
Table 74. Bayer Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Triad Isotopes Company Details
Table 77. Triad Isotopes Business Overview
Table 78. Triad Isotopes Nuclear Medicine Product
Table 79. Triad Isotopes Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 80. Triad Isotopes Recent Development
Table 81. Nordion Company Details
Table 82. Nordion Business Overview
Table 83. Nordion Nuclear Medicine Product
Table 84. Nordion Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 85. Nordion Recent Development
Table 86. Jubilant Pharma Company Details
Table 87. Jubilant Pharma Business Overview
Table 88. Jubilant Pharma Nuclear Medicine Product
Table 89. Jubilant Pharma Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 90. Jubilant Pharma Recent Development
Table 91. Eli Lilly Company Details
Table 92. Eli Lilly Business Overview
Table 93. Eli Lilly Nuclear Medicine Product
Table 94. Eli Lilly Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 95. Eli Lilly Recent Development
Table 96. SIEMENS Company Details
Table 97. SIEMENS Business Overview
Table 98. SIEMENS Nuclear Medicine Product
Table 99. SIEMENS Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 100. SIEMENS Recent Development
Table 101. China Isotope & Radiation Company Details
Table 102. China Isotope & Radiation Business Overview
Table 103. China Isotope & Radiation Nuclear Medicine Product
Table 104. China Isotope & Radiation Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 105. China Isotope & Radiation Recent Development
Table 106. Dongcheng Company Details
Table 107. Dongcheng Business Overview
Table 108. Dongcheng Nuclear Medicine Product
Table 109. Dongcheng Revenue in Nuclear Medicine Business (2020-2025) & (US$ Million)
Table 110. Dongcheng Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Nuclear Medicine Picture
Figure 2. Global Nuclear Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nuclear Medicine Market Share by Type: 2024 VS 2031
Figure 4. Tc-99 Features
Figure 5. I-123/131 Features
Figure 6. In-111 Features
Figure 7. Xe-133 Features
Figure 8. Th-201 Features
Figure 9. Ga-67 Features
Figure 10. Others Features
Figure 11. Global Nuclear Medicine Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Nuclear Medicine Market Share by Application: 2024 VS 2031
Figure 13. Diagnostic Case Studies
Figure 14. Therapeutic Case Studies
Figure 15. Nuclear Medicine Report Years Considered
Figure 16. Global Nuclear Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Nuclear Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Nuclear Medicine Market Share by Region: 2024 VS 2031
Figure 19. Global Nuclear Medicine Market Share by Players in 2024
Figure 20. Global Top Nuclear Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Medicine as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Nuclear Medicine Revenue in 2024
Figure 22. North America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Nuclear Medicine Market Share by Country (2020-2031)
Figure 24. United States Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Nuclear Medicine Market Share by Country (2020-2031)
Figure 28. Germany Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Nuclear Medicine Market Share by Region (2020-2031)
Figure 36. China Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Nuclear Medicine Market Share by Country (2020-2031)
Figure 44. Mexico Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Nuclear Medicine Market Share by Country (2020-2031)
Figure 48. Turkey Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Nuclear Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. GE Healthcare Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 52. Bracco Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 53. Mallinckrodt Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 54. Lantheus Medical Imaging Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 55. Bayer Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 56. Triad Isotopes Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 57. Nordion Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 58. Jubilant Pharma Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 59. Eli Lilly Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 60. SIEMENS Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 61. China Isotope & Radiation Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 62. Dongcheng Revenue Growth Rate in Nuclear Medicine Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Krypton Flash Lamp Market Research Report 2025
May 12, 25
Global IR Halogen Lamp Market Research Report 2025
May 12, 25
Global Halogen IR Lamp Market Research Report 2025
May 12, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232